Phase-1 Unit

September 4, 2022admin

Our cooperating phase I unit at Northwest Hospital in Frankfurt / University Cancer Center Frankfurt offers up to 12 in- or day-patient beds with full access to the intensive and emergency care units:

Welcome to the Phase 1 Unit, where we are dedicated to providing the highest quality of care to patients with cancer. In the Phase I unit, a therapy is applied to humans for the first time and its tolerability is investigated.
At our clinic, we understand that a cancer diagnosis can be overwhelming and frightening. Our team of highly skilled and experienced healthcare professionals is here to support you every step of the way. We will work collaboratively with you to develop a personalized treatment plan that addresses your specific needs and goals.
We are committed to advancing cancer research and offer our patients the opportunity to participate in clinical trials. By participating in these trials, you will have access to the latest cancer treatments before they are widely available.

Read More

team3

September 4, 2022admin

Staff

Over the years, our work has earned us an outstanding reputation in the field of oncology clinical trials. However, this is not solely a consequence of the ground-breaking scientific results we have achieved in close cooperation with our research partners. Above all, we owe our success to the extraordinary dedication, wisdom, and sense of responsibility of our employees.

 

Our staff is dynamic, multidisciplinary and highly experienced. The background of our employees often comprises a high degree (PhD) in medical or natural sciences. Beside medical professionals, our team comprises biologists, human biologists, bioinformaticians, data managers, monitors (clinical research associates), statisticians, chemists, and others.

Team

PROF. DR. MED. SALAH-EDDIN AL-BATRAN

Founder and Managing Director of IKF

Over the years, our work has earned us an outstanding reputation in the field of oncology clinical trials. However, this is not solely a consequence of the ground-breaking scientific results we have achieved in close cooperation with our research partners. Above all, we owe our success to the extraordinary dedication, wisdom, and sense of responsibility of our employees.

Our team embodies the following traits: clear communication, collaboration, open-mindedness, flexibility, accountability, trust, and service mentality. The background of our employees often comprises a high degree (PhD) in medical or natural sciences. Beside medical professionals, our team comprises biologists, human biologists, bioinformaticians, statisticians, chemists, and others.

With our multidisciplinary and highly specialized expertise, we bring a wealth of knowledge and diverse perspectives to problem-solving and decision-making.

PROF. DR. MED. SALAH-EDDIN AL-BATRAN

Founder and Managing Director of IKF

Over the years, our work has earned us an outstanding reputation in the field of oncology clinical trials. However, this is not solely a consequence of the ground-breaking scientific results we have achieved in close cooperation with our research partners. Above all, we owe our success to the extraordinary dedication, wisdom, and sense of responsibility of our employees.

Our team embodies the following traits: clear communication, collaboration, open-mindedness, flexibility, accountability, trust, and service mentality. The background of our employees often comprises a high degree (PhD) in medical or natural sciences. Beside medical professionals, our team comprises biologists, human biologists, bioinformaticians, statisticians, chemists, and others.

With our multidisciplinary and highly specialized expertise, we bring a wealth of knowledge and diverse perspectives to problem-solving and decision-making.

Read More

Service

September 4, 2022admin

We understand the importance of advancing science-driven research, and our collaborative models offer academic and biotech partners clear advantages over the classical CRO business

Your Partner for Collaborative Clinical Trials in Academia and Science-Driven Biotech

At IKF, we understand the importance of advancing science-driven research. Founded by oncologists who have conducted their own trials, we know the unique needs and challenges faced by academic groups and innovative biotech companies.

What sets us apart is our collaborative research philosophy. Through different models of collaboration, we work hand-in-hand with our partners to create solutions for the development of new therapies and medicines that offer significant advantages over the classical pharma-CRO business model.

Our commitment to academic and science-driven biotech partners extends beyond financial considerations. We recognize the realities of limited budgets and milestone-dependent funding and therefore engage in risk-sharing approaches.

If you would like to learn more about our collaborative models and how IKF can support your research, please contact us.

IKF operates its own Comprehensive Research Organization (CRO)

Comprehensive Research Organization (CRO) at IKF

For collaborative clinical trials, IKF has established its own high-quality Comprehensive Research Organization (CRO). This ensures full sponsor responsibilities, strict regulatory compliance, and operational excellence throughout all phases of clinical research.

Our services include (but are not limited to):

Read MoreRead Less

Data Management

Our data management focuses on quality control and data integrity of the clinical trial database – from database setup to database lock. We provide specification and development of user-friendly electronic case report forms (eCRFs) based on a well-structured database to ensure high-quality data for statistical analysis.

Read MoreRead Less

Statistics

Statistical parameters play an important role in ensuring the overall success of a clinical trial. Therefore, our statistics team is involved in the planning of any clinical trial from the very beginning and accompanies it through all trial stages, closely cooperating with the data management.

Read MoreRead Less

Read More

Own Research

September 4, 2022admin

Our “product” is the gain of scientific knowledge

Excellence in Research

Our research activities have a clear objective: to conduct and facilitate excellent clinical cancer research at the international level in order to improve the treatment and quality of life of cancer patients. As we are not a pharmaceutical company, our real “product” is the gain of scientific knowledge, which we achieve through clinical trials with our partners that focus on patient-relevant endpoints such as survival and quality of life.

Our trials have gained worldwide recognition for their significant impact on the field of cancer care

Investigator-initiated (non-pharma-sponsored) research

Sponsored by our institution and conducted on an international scale, our investigator-initiated trials result from collaborative efforts between our internal experts and external partners, including esteemed physicians and oncologists from various university hospitals.

Read MoreRead Less

We aim to accelerate the translation of research findings into tangible benefits for patients

Translational Research and BioDataBank

We recognize the vital role of translational research in our study designs. By integrating translational elements and artificial intelligence (AI), we are committed to advancing the understanding of cancer pathogenesis and development.

To support researchers in gaining valuable insights, we systematically collect specimens such as tissue, blood, and stool whenever possible. These biospecimens, together with associated clinical trial data, are curated in the IKF BioDataBank, a comprehensive resource that already contains more than 22,000 tissue samples. This unique combination provides an invaluable foundation for studying cancer at the molecular level.

To guarantee responsible use, access to the BioDataBank is governed by a stringent ethical and governance framework.

Read MoreRead Less

Real-World Evidence and Non-Interventional Research

One focus of our research lies in real-world studies across diverse healthcare settings. These studies provide valuable insights into the practical application of treatments, their effectiveness in routine care, and patient outcomes in real-world scenarios.

Our collaborative real-world studies and non-interventional trials are characterized by high scientific impact and enjoy strong acceptance within the oncology community.

By conducting research in real-life settings, we aim to bridge the gap between controlled clinical environments and the complexities of everyday practice — generating evidence that truly informs and improves patient care.

Read More

Linkedin Instagram Envelope

Frankfurter Institut für Klinische Krebsforschung IKF GmbH
Steinbacher Hohl 2-26
60488 Frankfurt am Main

Copyright © IKF GmbH 2024 all rights reserved